bluebird bio (BLUE) Tops Q3 EPS by 5c

bluebird bio (NASDAQ: BLUE) reported Q3 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $18.05 million.

For earnings history and earnings-related data on bluebird bio (BLUE) click here.

You May Also Be Interested In

• Cantor Fitzgerald Reiterates Overweight Rating on Onto Innovation Inc. (ONTO) Ahead of Q2 Print
• Instacart and Tractor Supply launch same-day delivery partnership
• Quantum Cyber files patent for modular drone launch system